BAX
Price
$23.86
Change
+$0.63 (+2.71%)
Updated
Oct 3 closing price
Capitalization
12.25B
25 days until earnings call
SYK
Price
$370.50
Change
+$4.10 (+1.12%)
Updated
Oct 3 closing price
Capitalization
141.64B
25 days until earnings call
Interact to see
Advertisement

BAX vs SYK

Header iconBAX vs SYK Comparison
Open Charts BAX vs SYKBanner chart's image
Baxter International
Price$23.86
Change+$0.63 (+2.71%)
Volume$6.55M
Capitalization12.25B
Stryker
Price$370.50
Change+$4.10 (+1.12%)
Volume$1.08M
Capitalization141.64B
BAX vs SYK Comparison Chart in %
BAX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SYK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BAX vs. SYK commentary
Oct 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BAX is a StrongBuy and SYK is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 06, 2025
Stock price -- (BAX: $23.86 vs. SYK: $370.50)
Brand notoriety: BAX and SYK are both not notable
BAX represents the Pharmaceuticals: Other, while SYK is part of the Medical/Nursing Services industry
Current volume relative to the 65-day Moving Average: BAX: 82% vs. SYK: 82%
Market capitalization -- BAX: $12.25B vs. SYK: $141.64B
BAX [@Pharmaceuticals: Other] is valued at $12.25B. SYK’s [@Medical/Nursing Services] market capitalization is $141.64B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $162.16B to $0. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $234.25B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $11.38B. The average market capitalization across the [@Medical/Nursing Services] industry is $5.58B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BAX’s FA Score shows that 2 FA rating(s) are green whileSYK’s FA Score has 2 green FA rating(s).

  • BAX’s FA Score: 2 green, 3 red.
  • SYK’s FA Score: 2 green, 3 red.
According to our system of comparison, SYK is a better buy in the long-term than BAX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BAX’s TA Score shows that 5 TA indicator(s) are bullish while SYK’s TA Score has 4 bullish TA indicator(s).

  • BAX’s TA Score: 5 bullish, 3 bearish.
  • SYK’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, BAX is a better buy in the short-term than SYK.

Price Growth

BAX (@Pharmaceuticals: Other) experienced а +8.55% price change this week, while SYK (@Medical/Nursing Services) price change was +0.63% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +4.63%. For the same industry, the average monthly price growth was +2.89%, and the average quarterly price growth was +20.22%.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was +2.81%. For the same industry, the average monthly price growth was +5.78%, and the average quarterly price growth was +19.30%.

Reported Earning Dates

BAX is expected to report earnings on Oct 30, 2025.

SYK is expected to report earnings on Oct 30, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (+4.63% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

@Medical/Nursing Services (+2.81% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SYK($142B) has a higher market cap than BAX($12.3B). BAX has higher P/E ratio than SYK: BAX (87.85) vs SYK (48.53). SYK YTD gains are higher at: 3.596 vs. BAX (-16.740). SYK has higher annual earnings (EBITDA): 5.76B vs. BAX (1.04B). BAX has less debt than SYK: BAX (9.73B) vs SYK (16.6B). SYK has higher revenues than BAX: SYK (23.8B) vs BAX (10.9B).
BAXSYKBAX / SYK
Capitalization12.3B142B9%
EBITDA1.04B5.76B18%
Gain YTD-16.7403.596-466%
P/E Ratio87.8548.53181%
Revenue10.9B23.8B46%
Total Cash1.69BN/A-
Total Debt9.73B16.6B59%
FUNDAMENTALS RATINGS
BAX vs SYK: Fundamental Ratings
BAX
SYK
OUTLOOK RATING
1..100
2213
VALUATION
overvalued / fair valued / undervalued
1..100
20
Undervalued
60
Fair valued
PROFIT vs RISK RATING
1..100
10020
SMR RATING
1..100
9256
PRICE GROWTH RATING
1..100
6460
P/E GROWTH RATING
1..100
3026
SEASONALITY SCORE
1..100
501

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

BAX's Valuation (20) in the Medical Specialties industry is somewhat better than the same rating for SYK (60). This means that BAX’s stock grew somewhat faster than SYK’s over the last 12 months.

SYK's Profit vs Risk Rating (20) in the Medical Specialties industry is significantly better than the same rating for BAX (100). This means that SYK’s stock grew significantly faster than BAX’s over the last 12 months.

SYK's SMR Rating (56) in the Medical Specialties industry is somewhat better than the same rating for BAX (92). This means that SYK’s stock grew somewhat faster than BAX’s over the last 12 months.

SYK's Price Growth Rating (60) in the Medical Specialties industry is in the same range as BAX (64). This means that SYK’s stock grew similarly to BAX’s over the last 12 months.

SYK's P/E Growth Rating (26) in the Medical Specialties industry is in the same range as BAX (30). This means that SYK’s stock grew similarly to BAX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BAXSYK
RSI
ODDS (%)
Bullish Trend 3 days ago
50%
Bullish Trend 3 days ago
68%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
69%
Bullish Trend 3 days ago
63%
Momentum
ODDS (%)
Bullish Trend 3 days ago
52%
Bearish Trend 3 days ago
52%
MACD
ODDS (%)
Bullish Trend 3 days ago
46%
Bearish Trend 3 days ago
50%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
54%
Bullish Trend 3 days ago
54%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
58%
Bearish Trend 3 days ago
46%
Advances
ODDS (%)
Bullish Trend 5 days ago
52%
Bullish Trend 3 days ago
54%
Declines
ODDS (%)
Bearish Trend 11 days ago
60%
Bearish Trend 11 days ago
51%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
57%
Bullish Trend 3 days ago
77%
Aroon
ODDS (%)
Bearish Trend 3 days ago
53%
Bearish Trend 3 days ago
44%
View a ticker or compare two or three
Interact to see
Advertisement
BAX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SYK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
RLTY15.360.15
+0.99%
Cohen & Steers Real Estate Opportunities and Income Fund
QLVD31.06N/A
N/A
FlexShares Dev Mks ex-US Qual Lw Vol ETF
SIXZ29.19N/A
N/A
AllianzIM US Lrg Cp 6M Bfr10 May/Nov ETF
PDX24.59-0.24
-0.97%
PIMCO Dynamic Income Strategy Fund
EFU9.53-0.15
-1.51%
ProShares UltraShort MSCI EAFE

BAX and

Correlation & Price change

A.I.dvisor indicates that over the last year, BAX has been closely correlated with ALGN. These tickers have moved in lockstep 72% of the time. This A.I.-generated data suggests there is a high statistical probability that if BAX jumps, then ALGN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BAX
1D Price
Change %
BAX100%
+2.71%
ALGN - BAX
72%
Closely correlated
+2.70%
LUNG - BAX
53%
Loosely correlated
+8.88%
STE - BAX
51%
Loosely correlated
+0.04%
SOLV - BAX
51%
Loosely correlated
-0.80%
SYK - BAX
51%
Loosely correlated
+1.12%
More